跳至主要内容
临床试验/NCT01161953
NCT01161953已完成不适用

Understanding the Genetic Predisposition to the Development of Primary Biliary Cirrhosis (PBC).

Mayo Clinic1 个研究点 分布在 1 个国家目标入组 1,500 人开始时间: 2002年3月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
Mayo Clinic
入组人数
1,500
试验地点
1
主要终点
Mapping of Susceptibility Genes in Adult Chronic Cholestatic Liver Diseases

研究概览

简要总结

Primary Biliary Cirrhosis (PBC) is a progressive liver disorder of unknown cause. Current evidence suggests that genes, the genetic material we inherit from our parents, in combination with environmental factors, likely play an important role in the development of PBC.

This study is being done to investigate whether genes make people more likely to develop PBC. Discovery of these proposed genes will help us better understand how PBC developes, and subsequently, to apply new approaches for its prevention, diagnosis and treatment.

研究设计

研究类型
Observational
观察模型
Family Based
时间视角
Other

入排标准

年龄范围
18 Years 至 90 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Men and women between the ages of 18-90 who have a history of PBC.
  • PBC patients who have undergone a liver transplant are eligible.
  • Family members (1st degree relatives) of enrolled PBC patients are eligible.

排除标准

  • Individuals with no history of PBC or those unable to provide consent.

结局指标

主要结局

Mapping of Susceptibility Genes in Adult Chronic Cholestatic Liver Diseases

Adult chronic cholestatic liver diseases, such as Primary Biliary Cirrhosis (PBC), are progressive liver disorders of unknown cause. Current evidence suggests that genes, the genetic material we inherit from our parents, in combination with environmental factors, likely play an important role in the development of PBC. This study is being done to investigate whether genes (the inherited genetic material passed from parents to their children) make people more likely to develop PBC. Discovery of these proposed genes will help us to better understand how PBC progresses, and subsequently, to apply new approaches for its prevention, diagnosis and treatment.

次要结局

未报告次要终点

研究者

发起方
Mayo Clinic
申办方类型
Other
责任方
Principal Investigator
主要研究者

Konstantinos N. Lazaridis, M.D.

Hepatology Consultant

Mayo Clinic

研究点 (1)

Loading locations...

相似试验

Genetic Epidemiology of Primary Biliary Cirrhosis... | 临床试验